Gene: ZNF561
Official Full Name: zinc finger protein 561provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22320 | ZNF561 Knockout cell line (HeLa) | Human | ZNF561 | 1:3~1:6 | Negative | Online Inquiry |
KO22321 | ZNF561 Knockout cell line (HCT 116) | Human | ZNF561 | 1:2~1:4 | Negative | Online Inquiry |
KO22322 | ZNF561 Knockout cell line (HEK293) | Human | ZNF561 | 1:3~1:6 | Negative | Online Inquiry |
KO22323 | ZNF561 Knockout cell line (A549) | Human | ZNF561 | 1:3~1:4 | Negative | Online Inquiry |
ZNF561 Gene Knockout Cell Lines are genetically engineered cellular models that facilitate the comprehensive study of the ZNF561 gene's function and its role in various biological processes. These cell lines are specifically designed to possess a knockout of the ZNF561 gene, allowing researchers to investigate the gene's contributions to cellular pathways, gene regulation, and disease mechanisms without the interference of its normal function. The knockout is achieved through precise gene editing techniques, such as CRISPR-Cas9, which ensures high specificity and efficiency in disrupting the target gene.
The key functionality of the ZNF561 gene knockout cell lines lies in their ability to mimic specific physiological conditions that are essential for understanding the pathophysiology of diseases like cancer, neurodegenerative disorders, and metabolic syndromes. By comparing these knockout cell lines to wild-type controls, researchers can elucidate the functional roles of ZNF561, potentially discovering novel therapeutic targets or biomarkers.
The scientific importance of utilizing ZNF561 knockout cell lines is particularly pronounced in both research and clinical settings. In laboratory research, these models enable high-throughput screening of drug candidates, allowing for a more informed development of therapeutics targeted at conditions influenced by ZNF561. In clinical contexts, insights gained from these studies contribute to personalized medicine approaches, guiding treatment strategies based on specific genetic profiles.
Compared to alternative models, such as transient knockdown systems or traditional knockout models with limited control, ZNF561 gene knockout cell lines offer unparalleled stability and reproducibility. Their robust knockout ensures that researchers can rely on consistent data across multiple experiments, ultimately leading to more reliable conclusions.
For researchers and clinicians alike, the ZNF561 gene knockout cell lines represent a crucial resource for advancing our understanding of gene function and pathology. The cellular models are invaluable for anyone looking to explore the intricacies of gene-environment interactions in human health and disease.
Our company prides itself on its innovative approach to providing high-quality biological products, and our expertise in genetic engineering assures the reliability and effectiveness of ZNF561 knockout cell lines in fostering cutting-edge research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.